Breast cancer screening: What does the future hold?: Overdiagnosis remains a problem Quantifying its effects and minimising its impact are priorities

BMJ (Online)

Volumn 346, Issue 7892, 2013, Pages

  Kirwan, Cliona C ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALOPECIA; ANXIETY; BIOASSAY; BREAST BIOPSY; BREAST CANCER; BREAST TOMOSYNTHESIS; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; CONSERVATIVE TREATMENT; DIAGNOSTIC ERROR; EDITORIAL; FRACTURE; HEALTH CARE COST; HEALTH CARE QUALITY; HOT FLUSH; HUMAN; INFORMATION DISSEMINATION; INTERNAL BIAS; INTRADUCTAL CARCINOMA; LUNG DISEASE; MAMMOGRAPHY; META ANALYSIS (TOPIC); METASTASIS; METHODOLOGY; NEUTROPENIA; OBSERVATIONAL STUDY; PAIN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEPSIS; SURGICAL RISK; TOMOGRAPHY; VAGINAL DRYNESS; WOMEN'S HEALTH;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; FORECASTING; HUMANS;

EID: 84873045570     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f87     Document Type: Editorial

References (12)

1. Anonymous. The benefits and harms of breast cancer screening: an independent review. Lancet 2012;380:1778-86.
2. NHS The Information Centre. Breast screening programme-England 2010-11. 2012. www.ic.nhs.uk/searchcatalogue?productid=4899&q= uptake+of+invitation+to+screen+breast+cancer&sort=Relevance&size= 10&page=1#top.
3. Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 2002;94:39-49.
4. Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2011;1:CD001877.
5. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Intern Med 2009;151:727-37; W237-42.
6. Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen TH, et al. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the breast screening programme in England. J Med Screen 2010;17:25-30.
7. Beral V, Alexander M, Duffy S, Ellis IO, Given-Wilson R, Holmberg L, et al. The number of women who would need to be screened regularly by mammography to prevent one death from breast cancer. J Med Screen 2011;18:210-2.
8. Jorgensen KJ, Gotzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ .2009;339:b2587.
9. Gunsoy NB, Garcia-Closas M, Moss SM. Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40-49 in the United Kingdom. Breast Cancer Res 2012;14:R152.
10. UK CR. Breast cancer mortality statistics. 2012. www.cancerresearchuk. org/cancer-info/cancerstats/types/breast/mortality/uk-breast-cancer-mortality- statistics.
11. Biesheuvel C, Barratt A, Howard K, Houssami N, Irwig L. Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol 2007;8:1129-38.
12. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007;356:227-36.